Yes, and just to echo your point, it is very difficult to manage that.
These are my final two points. One, we'd be happy to put that together. I have a brilliant team who can help pull some information, and we would submit it to the committee for review. We have to have a starting place. There has to be someplace where we start. That would be one thing.
The other thing is that, as we have talked about today in terms of these other new remedies, the U.K. is doing some very remarkable work. There is one individual there, Mr. John Carr. We've been in communication with him about some of these new remedies it's putting forward. It might be worth the committee's time to have him join you by video conference to walk the committee through some of the hurdles it went through, how it did the consultations, and what some of the outcomes of those efforts were. It is doing some really important things there.